Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Toshihito Furukawa"'
Autor:
Mitsuhiro Tambo, Shigeo Horie, Shinya Kaname, Toshihito Furukawa, Tatsuya Yoshioka, Satoru Taguchi, Tsuyoshi Yamaguchi, Haruna Kawano, Eiji Higashihara, Satoru Muto, Hiroshi Fukuhara, Kenich Yokoyama
Publikováno v:
American Journal of Nephrology. 51:881-890
Background: Tolvaptan was approved for the treatment of autosomal dominant polycystic kidney disease (ADPKD). However, the official indication of “rapidly progressive disease” is described differently in the clinical guidelines. We aim to define
Autor:
Toshihito Furukawa, Shigetaka Kanda, Yoshiaki Sakai, Keiichi Ashikaga, Kazumasa Adachi, Kenji Ando, Natsuhiko Ehara, Fumiharu Miura, Hiroyuki Yoshimura
Publikováno v:
International Heart Journal. 59:1002-1007
Several studies have reported that the left ventricular (LV) lead implant success rate ranges between 88.0% and 92.4%. Coronary venous anatomy differs among patients thus, necessitating multiple types of leads. To date, the implant success rate among
Autor:
Kenji, Ando, Shigetaka, Kanda, Fumiharu, Miura, Keiichi, Ashikaga, Natsuhiko, Ehara, Yoshiaki, Sakai, Toshihito, Furukawa, Hiroyuki, Yoshimura, Kazumasa, Adachi
Publikováno v:
International heart journal. 59(5)
Several studies have reported that the left ventricular (LV) lead implant success rate ranges between 88.0% and 92.4%. Coronary venous anatomy differs among patients thus, necessitating multiple types of leads. To date, the implant success rate among
Autor:
Toshihito Furukawa, Satoru Otsuji, Yoshihisa Nakagawa, Nobuo Shiode, Propel Investigators, Masato Nakamura, Gaku Nakazawa, Hiroyoshi Yokoi, Masatoshi Miyahara, Yuji Oikawa
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 82(9)
BACKGROUND The Resolute Integrity coronary drug-eluting stent (DES), the next evolution of the Resolute DES, is designed with thinner stent struts and continuous sinusoidal technology to further enhance performance. This study evaluated the performan
Autor:
Hitomi Hagiwara, Kiyoshi Matsumura, Toshihito Furukawa, Atsushi Sakaoka, Kenichi Sakakura, Shintaro Nakamura, Hisako Terao
Publikováno v:
Circulation. Cardiovascular Interventions
Background— Ablation lesion depth caused by radiofrequency-based renal denervation (RDN) was limited to Methods and Results— Radiofrequency was delivered to 87 sites in 14 renal arteries from 9 farm pigs at various ablation settings: 2, 4, 6, and
Autor:
Atsushi Sakaoka, Hisako Terao, Shintaro Nakamura, Hitomi Hagiwara, Toshihito Furukawa, Kiyoshi Matsumura, Kenichi Sakakura
Publikováno v:
Circulation: Cardiovascular Interventions; Feb2018, Vol. 11 Issue 2, p1-8, 8p
Publikováno v:
Journal of Epidemiology
BACKGROUND: Coronary heart disease occurs nearly exponentially with age and differently between men and women. Therefore, difference in sex and age of family members yields errors in assessing the family history as a risk factor. The influence of sex
Autor:
Takayuki Inomata, Shin-ichi Momomura, Narumi Koga, Yuji Watari, Yasukazu Fujiwara, Toshihito Furukawa, Masatsugu Nozoe, Taishi Hirahara, Akihiro Nakamura, Toshiaki Kadokami, Nobuhimo Atsuchi, Masayuki Doi, Masahiro Sonoda, Hitoshi Nakashima
Publikováno v:
Journal of Cardiac Failure. 22:S196
Publikováno v:
Journal of Epidemiology. 5:109-112
Age is a major variable to be considered in epidemiology. But age of family members is not considered at all or its consideration seems inadequate in studies on assessing the family history of coronary heart disease as a risk factor. In this report t
Autor:
Akiharu Watanabe, Toshihito Furukawa, Masayuki Niwa, Kuniko Taguchi, Masayoshi Takahashi, Seiji Saito, Kazuei Ogoshi, Nobuyuki Nishimura
Publikováno v:
Cancer. 72:381-388
Background. There has been extensive use of serum tumor markers in diagnosing pancreatic adenocarcinoma. There is no tumor marker, however, that alone has sufficient diagnostic accuracy. It is necessary to know which combination of tumor markers shou